1 |
Parkinson disease (P00049) |
3 |
7.7 |
2 |
Angiogenesis (P00005) |
2 |
5.1 |
3 |
Vasopressin synthesis (P04395) |
2 |
5.1 |
4 |
Blood coagulation (P00011) |
2 |
5.1 |
5 |
T cell activation (P00053) |
2 |
5.1 |
6 |
TCA cycle (P00051) |
2 |
5.1 |
7 |
Methionine biosynthesis (P02753) |
1 |
2.6 |
8 |
Tryptophan biosynthesis (P02783) |
1 |
2.6 |
9 |
Axon guidance mediated by Slit/Robo (P00008) |
1 |
2.6 |
10 |
Opioid prodynorphin pathway (P05916) |
1 |
2.6 |
11 |
Integrin signaling pathway (P00034) |
1 |
2.6 |
12 |
Adrenaline and noradrenaline biosynthesis (P00001) |
1 |
2.6 |
13 |
Inflammation mediated by chemokine and cytokine signaling pathway (P00031) |
1 |
2.6 |
14 |
Dopamine receptor mediated signaling pathway (P05912) |
1 |
2.6 |
15 |
Angiotensin II-stimulated signaling through G proteins and beta-arrestin (P05911) |
1 |
2.6 |
16 |
Gonadotropin releasing hormone receptor pathway (P06664) |
1 |
2.6 |
17 |
Vitamin D metabolism and pathway (P04396) |
1 |
2.6 |
18 |
PDGF signaling pathway (P00047) |
1 |
2.6 |
19 |
Cytoskeletal regulation by Rho GTPase (P00016) |
1 |
2.6 |
20 |
Nicotine pharmacodynamics pathway (P06587) |
1 |
2.6 |
21 |
Cholesterol biosynthesis (P00014) |
1 |
2.6 |
22 |
B cell activation (P00010) |
1 |
2.6 |
23 |
CCKR signaling map (P06959) |
1 |
2.6 |
24 |
Heme biosynthesis (P02746) |
1 |
2.6 |
25 |
Pyruvate metabolism (P02772) |
1 |
2.6 |
26 |
Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction (P00028) |
1 |
2.6 |
27 |
Flavin biosynthesis (P02741) |
1 |
2.6 |
28 |
Wnt signaling pathway (P00057) |
1 |
2.6 |
29 |
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway (P00026) |
1 |
2.6 |
30 |
VEGF signaling pathway (P00056) |
1 |
2.6 |
31 |
Ascorbate degradation (P02729) |
1 |
2.6 |
32 |
Plasminogen activating cascade (P00050) |
1 |
2.6 |